Anti-PHB2/ BAP/ BCAP37 monoclonal antibody
Anti-PHB2/ BAP/ BCAP37 antibody for FACS & in-vivo assay
Go to PHB2/PHB2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1361-Ab-1/ GM-Tg-hg-MP1361-Ab-2 | Anti-Human PHB2 monoclonal antibody | Human |
GM-Tg-rg-MP1361-Ab-1/ GM-Tg-rg-MP1361-Ab-2 | Anti-Rat PHB2 monoclonal antibody | Rat |
GM-Tg-mg-MP1361-Ab-1/ GM-Tg-mg-MP1361-Ab-2 | Anti-Mouse PHB2 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1361-Ab-1/ GM-Tg-cynog-MP1361-Ab-2 | Anti-Cynomolgus/ Rhesus macaque PHB2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1361-Ab-1/ GM-Tg-felg-MP1361-Ab-2 | Anti-Feline PHB2 monoclonal antibody | Feline |
GM-Tg-cang-MP1361-Ab-1/ GM-Tg-cang-MP1361-Ab-2 | Anti-Canine PHB2 monoclonal antibody | Canine |
GM-Tg-bovg-MP1361-Ab-1/ GM-Tg-bovg-MP1361-Ab-2 | Anti-Bovine PHB2 monoclonal antibody | Bovine |
GM-Tg-equg-MP1361-Ab-1/ GM-Tg-equg-MP1361-Ab-2 | Anti-Equine PHB2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1361-Ab-1/ GM-Tg-hg-MP1361-Ab-2; GM-Tg-rg-MP1361-Ab-1/ GM-Tg-rg-MP1361-Ab-2; GM-Tg-mg-MP1361-Ab-1/ GM-Tg-mg-MP1361-Ab-2; GM-Tg-cynog-MP1361-Ab-1/ GM-Tg-cynog-MP1361-Ab-2; GM-Tg-felg-MP1361-Ab-1/ GM-Tg-felg-MP1361-Ab-2; GM-Tg-cang-MP1361-Ab-1/ GM-Tg-cang-MP1361-Ab-2; GM-Tg-bovg-MP1361-Ab-1/ GM-Tg-bovg-MP1361-Ab-2; GM-Tg-equg-MP1361-Ab-1/ GM-Tg-equg-MP1361-Ab-2 |
Products Name | Anti-PHB2 monoclonal antibody |
Format | mab |
Target Name | PHB2 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-PHB2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species PHB2/ BAP/ BCAP37 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | vGMLV000381 | human vGM2 Lentivirus particle |
ORF Viral Vector | pGMLV000381 | human pGM2 Lentivirus plasmid |
ORF Viral Vector | pGMLPm002593 | mouse pGM2 Lentivirus plasmid |
ORF Viral Vector | vGMLPm002593 | mouse vGM2 Lentivirus particle |
Target information
Target ID | GM-MP1361 |
Target Name | PHB2 |
Gene ID | 11331,12034,114766,714693,486716,101087932,515363,100052934 |
Gene Symbol and Synonyms | BAP,Bap-37,Bap37,Bcap27,BCAP37,hBAP,p22,PHB2,PNAS-141,REA |
Uniprot Accession | Q99623,Q5XIH7,Q2HJ97 |
Uniprot Entry Name | PHB2_HUMAN,PHB2_RAT,PHB2_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000215021 |
Target Classification | N/A |
The target: PHB2, gene name: PHB2, also named as BAP, BCAP37, Bap37, PNAS-141, REA, hBAP, p22. Enables several functions, including protein C-terminus binding activity; protein N-terminus binding activity; and protein dimerization activity. Involved in several processes, including defense response to virus; positive regulation of cell cycle phase transition; and regulation of transcription, DNA-templated. Located in several cellular components, including cell surface; mitochondrial membrane; and nuclear matrix. Part of mitochondrial prohibitin complex. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.